Similar articles

• Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment: a cause of chronic liver disease after kidney transplantation.

  Gerlag PG, van Hooff JP. Gerlag PG, et al. Transplant Proc. 1987 Oct;19(5):3699-703. Transplant Proc. 1987. PMID: 3313895 No abstract available.
• Hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine.

  Marubbio AT, Danielson B. Marubbio AT, et al. Gastroenterology. 1975 Sep;69(3):739-43. Gastroenterology. 1975. PMID: 1098955
• Irreversible liver damage after azathioprine.

  Zarday Z, Veith FJ, Gliedman ML, Soberman R. Zarday Z, et al. JAMA. 1972 Nov 6;222(6):690-1. JAMA. 1972. PMID: 4562099 No abstract available.
• Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literature.

  Dooremont D, Decaestecker J, De Wulf D, Ghillebert G, Van Vlierberghe H, Van Dorpe J, Baert F. Dooremont D, et al. Acta Gastroenterol Belg. 2013 Sep;76(3):342-6. Acta Gastroenterol Belg. 2013. PMID: 24261031 Review.
• [Drug induced liver disease (author's transl)].

  Knoblauch M. Knoblauch M. Ther Umsch. 1978 Sep;35(9):747-55. Ther Umsch. 1978. PMID: 360476 Review. German. No abstract available.